Exp Clin Endocrinol Diabetes 2019; 127(07): 477-484
DOI: 10.1055/s-0043-125315
Article
© Georg Thieme Verlag KG Stuttgart · New York

Combining Various Methods to Assess Insulin Sensitivity in Nonobese Rat after Sleeve Gastrectomy

Dong Sun
1   Department of General Surgery, Qilu Hospital of Shandong University, Jinan 250012, Shandong, People’s Republic of China
,
Yanmin Wang
2   Department of General Surgery, Qianfo Shan Hospital Affiliated to Shandong University, Jinan, 250014, Shandong, People’s Republic of China
,
Meng Wei
1   Department of General Surgery, Qilu Hospital of Shandong University, Jinan 250012, Shandong, People’s Republic of China
,
Zongli Zhang*
1   Department of General Surgery, Qilu Hospital of Shandong University, Jinan 250012, Shandong, People’s Republic of China
,
Sanyuan Hu*
1   Department of General Surgery, Qilu Hospital of Shandong University, Jinan 250012, Shandong, People’s Republic of China
› Author Affiliations
Further Information

Publication History

received 01 October 2017
revised 30 November 2017

accepted 21 December 2017

Publication Date:
08 February 2018 (online)

Abstract

Background Sleeve gastrectomy (SG) procedure has been proved to improve insulin sensitivity and sustain anti-diabetic effects. Our aim is to co-use several methods to measure insulin sensitivity and investigate the effect of SG on hepatic and peripheral insulin sensitivity at early and long-term stages of postoperation.

Methods Thirty 11-week-old male Goto-Kakizaki rats were divided into SG, sham-operated SG (SOSG), and control groups. They were observed before operation and for 36 weeks of postoperation. Insulin tolerance test (ITT) and homeostasis model of assessment for insulin resistance index(HOMA-IR)were used to measure insulin resistance before operations and at 2 and 36 weeks of postoperation; Pyruvate challenge test (PCT) was administrated to assess the gluconeogenesis capability in order to reflect hepatic insulin sensitivity before operation and at 2 and 36 weeks of postoperation; Hyperinsulinemic euglycemic clamps (HIEC) was conducted before operation and at 2 and 36 weeks of postoperation to calculate the endogenous hepatic glucose production (HGP) at the basal and steady-state for evaluation of hepatic insulin sensitivity, and calculate the exogenous glucose infusion rate (GIR) at the steady-state for evaluation of peripheral insulin sensitivity.

Results The data showed that compared with rats in the sham and control groups, rats in SG group had 1) significantly lower AUCITT, HOMA-IR and AUC PCT values at 2 and 36 weeks of postoperation, 2) lower basal state HGP, but not steady-state GIR at 2 weeks of postoperation, and 3) significantly different basal and steady-state HGP and steady-state GIR at 36 weeks of postoperation. In addition, the basal and steady-state HGP and the steady-state GIR were significantly different between rats in SG group at 2 and 36 weeks of postoperation.

Conclusions This study explored insulin sensitivity of rats after SG by jointly using a variety of techniques. The results showed that SG time-dependently improved the hepatic and peripheral insulin sensitivity.

* Sanyuan Hu and Zongli Zhang contributed equally to this work.


 
  • References

  • 1 Sjöström L, Lindroos AK, Peltonen M. et al. Lifestyle, diabetes,and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 2683-2693
  • 2 Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg 2013; 23: 427-436
  • 3 Wu Q, Zhang X, Zhong M. et al. Effects of bariatric surgery on serum bile acid composition and conjugation in a diabetic rat model. Obes Surg 2016; 26: 2384-2392
  • 4 Schauer PR, Kashyap SR, Wolski K. et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012; 366: 1567-1576
  • 5 Yip S, Plank LD, Murphy R. Gastric bypass and sleeve gastrectomy for type 2 diabetes: A systematic review and meta-analysis of outcomes. Obes Surg 2013; 23: 1994-2003
  • 6 Vidal J, Ibarzabal A, Romero F. et al. Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obes Surg 2008; 18: 1077-1082
  • 7 Wilcox G. Insulin and insulin resistance. Clin Biochem Rev 2005; 26: 19-39
  • 8 Sun D, Liu S, Zhang G. et al. Sub-sleeve gastrectomy achieves good diabetes control without weight loss in a non-obese diabetic rat model. Surg Endosc 2014; 28: 1010-1018
  • 9 Sun D, Liu S, Zhang G. et al. Type 2 diabetes control in a nonobese rat model using sleeve gastrectomy with duodenal-jejunal bypass (SGDJB). Obes Surg 2012; 22: 1865-1873
  • 10 Ayala JE, Bracy DP, Malabanan C et al. Hyperinsulinemic-euglycemic clamps in conscious, unrestrained mice. J Vis Exp 2011; 16: pii: 3188
  • 11 de Bona Castelan J, Bettiol J, d'Acampora AJ. et al. Sleeve gastrectomy model in Wistar rats. Obes Surg 2007; 17: 957-961
  • 12 Pereferrer FS, Gonzàlez MH, Rovira AF. et al. Influence of sleeve gastrectomy on several experimental models of obesity: Metabolic and hormonal implications. Obes Surg 2008; 18: 97-108
  • 13 Matthews DR, Hosker JP, Rudenski AS. et al. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419
  • 14 Rodgers JT, Puigserver P. Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1. Proc Natl Acad Sci USA 2007; 31104: 12861-12866
  • 15 Abbatini F, Rizzello M, Casella G. et al. Long-term effects of laparoscopicsleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc 2010; 24: 1005-1010
  • 16 Karamanakos SN, Vagenas K, Kalfarentzos F. et al. Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study. Ann Surg 2008; 247: 401-407
  • 17 Basso N, Capoccia D, Rizzello M. et al. First-phase insulin secretion,insulin sensitivity, ghrelin, GLP-1, and PYY changes 72 h after sleeve gastrectomy in obese diabetic patients: The gastric hypothesis. Surg Endosc 2011; 25: 3540-3550
  • 18 Tymitz K, Engel A, McDonough S. et al. Changes in ghrelin levels following bariatric surgery: Review of the literature. Obes Surg 2011; 21: 125-130
  • 19 Dezaki K, Sone H, Yada T. Ghrelin is a physiological regulator of insulin release in pancreatic islets and glucose homeostasis. Pharmacol Ther 2008; 118: 239-249
  • 20 Monzillo LU, Hamdy O. Evaluation of insulin sensitivity in clinical practice and in research settings. Nutr Rev 2003; 61: 397-412
  • 21 Gelding SV, Robinson S, Lowe S. et al. Validation of the low dose short insulin tolerance test for evaluation of insulin sensitivity. Clin Endocrinol (Oxf) 1994; 40: 611-615
  • 22 Liu S, Zhang G, Wang L. et al. The entire small intestine mediates the changes in glucose homeostasis after intestinal surgery in Goto-Kakizaki rats. Ann Surg 2012; 256: 1049-1058
  • 23 Yan Z, Chen W, Liu S. et al. Myocardial insulin signaling and glucose transport are up-regulated in Goto-Kakizaki type 2 diabetic rats after ileal transposition. Obes Surg 2012; 22: 493-501
  • 24 Chen W, Yan Z, Liu S. et al. The changes of pro-opiomelanocortin neurons in type 2 diabetes mellitus rats after ileal transposition: the role of POMC neurons. J Gastrointest Surg 2011; 15: 1618-1624
  • 25 Li F, Zhang G, Liang J. et al. Sleeve gastrectomy provides a better control of diabetes by decreasing ghrelin in the diabetic Goto-Kakizaki rats. J Gastrointest Surg 2009; 13: 2302-2308
  • 26 Ballantyne GH, Wasielewski A, Saunders JK. The surgical treatment of type II diabetes mellitus: Changes in HOMA Insulin resistance in the first year following laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic adjustable gastric banding (LAGB). Obes Surg 2009; 19: 1297-1303
  • 27 Troy S, Soty M, Ribeiro L. et al. Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastriclap-band in mice. Cell Metab 2008; 8: 201-211
  • 28 Yassin K, Huyen VT, Hoa KN. et al. Herbal extract of gynostemma pentaphyllum decreases hepatic glucose output in type 2 diabetic goto-kakizaki rats. Int J Biomed Sci 2011; 7: 131-136